Successful High Flow Nasal Oxygen Therapy for Excessive Dynamic Airway Collapse: A Case Report.
10.4046/trd.2015.78.4.455
- Author:
Jisoo PARK
1
;
Yeon Joo LEE
;
Se Joong KIM
;
Jong Sun PARK
;
Ho Il YOON
;
Jae Ho LEE
;
Choon Taek LEE
;
Young Jae CHO
Author Information
1. Division of Pulmonology, Department of Internal Medicine, CHA University, CHA Bundang Medical Center, Seongnam, Korea.
- Publication Type:Case Report
- Keywords:
Airway Obstruction;
Oxygen Inhalation Therapy;
Pressure
- MeSH:
Aged, 80 and over;
Airway Obstruction;
Anti-Bacterial Agents;
Bronchoscopy;
Cartilage;
Diagnosis;
Dyspnea;
Edema;
Exhalation;
Female;
Heart;
Heart Failure;
Humans;
Oxygen Inhalation Therapy;
Oxygen*;
Patients' Rooms;
Pneumonia;
Positive-Pressure Respiration;
Renal Replacement Therapy;
Respiration, Artificial;
Respiratory Insufficiency
- From:Tuberculosis and Respiratory Diseases
2015;78(4):455-458
- CountryRepublic of Korea
- Language:English
-
Abstract:
Excessive dynamic airway collapse (EDAC) is a disease entity of excessive reduction of the central airway diameter during exhalation, without cartilage collapse. An 80-year-old female presented with generalized edema and dyspnea at our hospital. The patient was in a state of acute decompensated heart failure due to pneumonia with respiratory failure. We accordingly managed the patient with renal replacement therapy, mechanical ventilation and antibiotics. Bronchoscopy confirmed the diagnosis of EDAC. We scheduled extubation after the improvement of pneumonia and heart condition. However, extubation failure occurred due to hypercapnic respiratory failure with poor expectoration. Her EDAC was improved in response to high flow nasal oxygen therapy (HFNOT). Subsequently, the patient was stabilized and transferred to the general ward. HFNOT, which generates physiologic positive end expiratory pressure (PEEP) effects, could be an alternative and effective management of EDAC. Further research and clinical trials are needed to demonstrate the therapeutic effect of HFNOT on EDAC.
